Oxaliplatin Injection, Solution
Product Images NDC 71288-171

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Oxaliplatin (NDC 71288-171). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Meitheal Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel – Oxaliplatin Injection, Usp 100 mg Premier Carton (Oxali 100mg Premier Carton)

Oxaliplatin 100 mg per 20 mL (5 mg per mL) injection, USP, intravenous solution. The label indicates it is a sterile, preservative-free aqueous solution for single-dose vial use, diluted prior to use with 5% dextrose injection only. Warning states no dilution with sodium chloride or chloride-containing solutions. Labeled for Meitheal Pharmaceuticals Inc., Chicago, IL, with storage and handling instructions included.*

FDA Label Image

Principal Display Panel – Oxaliplatin Injection, Usp 100 mg Premier Vial Label (Oxali 100mg Premier Vial)

Oxaliplatin injection, USP 100 mg per 20 mL (5 mg per mL) in a 20 mL single-dose vial. The label indicates it is a sterile aqueous solution preservative free, for intravenous use only, and cautions against dilution in sodium chloride/chloride-containing solutions. The labeler is Meitheal Pharmaceuticals Inc.*

FDA Label Image

Principal Display Panel – Oxaliplatin Injection, Usp 50 mg Premier Carton (Oxali 50mg Premier Carton)

Packaging label for Oxaliplatin Injection, USP 50 mg per 10 mL (5 mg per mL) intravenous solution by Meitheal Pharmaceuticals Inc. The sterile, preservative-free single-dose vial must be diluted prior to use with 5% dextrose injection. The label includes caution against diluting in sodium chloride solutions and storage instructions.*

FDA Label Image

Principal Display Panel – Oxaliplatin Injection, Usp 50 mg Premier Vial Label (Oxali 50mg Premier Vial)

Oxaliplatin Injection USP 50 mg per 10 mL (5 mg per mL) sterile aqueous solution for intravenous use. Single-dose vial with warnings including 'Do not dilute in sodium chloride/ chloride-containing solutions,' manufactured by Meitheal Pharmaceuticals Inc., Chicago, IL. Label includes caution for cytotoxic agent and storage instructions.*

FDA Label Image

Figure 1 (Oxali Premier Fig 1)

A Kaplan-Meier survival curve comparing disease-free survival (DFS) probabilities over months for two treatment arms, FOLFOX4 and LV5FU2. The chart includes a legend indicating event numbers and percentages, hazard ratio with 95% confidence interval, and a logrank test p-value. Also displayed is the number of patients at risk over time for each arm.*

FDA Label Image

Figure 2 (Oxali Premier Fig 2)

A Kaplan-Meier survival curve chart depicting disease-free survival (DFS) probability over time in months. The chart compares two treatment arms labeled 'FOLFOX4 - DUKES C' and 'LV5FU2 - DUKES C'. Key statistics include a hazard ratio with 95% confidence interval and a p-value from the Logrank test. The x-axis represents DFS duration in months; the y-axis shows DFS probability.*

FDA Label Image

Figure 3 (Oxali Premier Fig 3)

A survival curve chart comparing median survival rates over 24 months for three chemotherapy regimens: Oxaliplatin with 5-FU/LV, Oxaliplatin with irinotecan, and Irinotecan with 5-FU/LV. The y-axis shows the percentage of patients surviving, and the x-axis shows time in months. Median survival months are 19.4, 17.6, and 14.6 respectively.*

FDA Label Image

Structure (Oxali Premier Structure)

Chemical structure of oxaliplatin, showing its platinum (Pt) center complexed with a 1,2-diaminocyclohexane ligand and oxalate groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.